Skip to main content
OpenTrials
Completed

NCT Number: NCT02660151

Study of Using the Hyper-CL™ Lens (Hyper Osmotic Contact Lens) in Subjects Suffering From Corneal Edema

The Hyper-CL™ lenses are indicated for therapeutic use as a bandage to protect the corneal surface and to relieve corneal pain in the treatment of acute or chronic ocular pathologies, such as bullous keratopathy, corneal erosions, entropion, corneal edema, and corneal dystrophies as well as post-surgical conditions resulting from cataract extraction and corneal surgery. The lenses may be prescribed for daily wear with removal for cleaning and disinfection (chemical, not heat) prior to reinsertion, as recommended by the eye care professional.

In addition Hyper-CL™ contact lenses can also provide optical correction during healing if required.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Corneal Edema Corneal Diseases Eye Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Soroka MC, Beersheba, Israel

Loading trial locations.

About this study

This study is a prospective, randomized crossover study. The primary aim of this study is to assess the safety and effectiveness of using the Hyper-CL™ lens +salt solution (5% NaCl) as compared with using regular contact lens + salt solution (5% NaCl) in subjects suffering from corneal edema. Safety will be assessed by evaluating the rate of adverse events and adverse device effects occurred throughout the study period. Effectiveness will be assessed by measuring changes in corneal thickness and visual acuity.

Subjects with corneal edema will be the study population. Only subjects who have signed the informed consent form and meet all the eligibility criteria listed below will be qualified for enrollment. The study will encompass a total of up to 80 subjects who will complete the Protocol follow-up schedule.

Each subject will be treated with:

Treatment A: Hyper-CL™ lens + salt solution + antibiotics drops (7 days) Treatment B: Regular soft contact lens +salt solution+ antibiotics drops (7 days) One week (7 days) of washout without any treatment will be between treatments. Subject will be equally allocated to one of the following 2 crossover regimen based on a randomization scheme with blocks stratified by center: A-B; B-A

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject is over 18 years old
  • Subject with corneal edema in the visual access
  • Subject with visual acuity of 6/20 or worse (equivalent ETDRS) clinically explained by corneal edema
  • Subject understands the study requirements and the treatment procedures and provides written Informed Consent before any study-specific tests or procedures are performed.

Exclusion criteria

  • Subject with active Herpes keratitis
  • Subject with scarred cornea
  • Subject who is suffering from erosions and/or infections of the cornea (red eye)
  • Subject with glaucoma shunts (e.g. Ahmed valve) and or bleb
  • Subject who require chronic administration of any topical ophthalmic beside lubrication eye drops and steroids or anti glaucoma drags
  • Subject who is currently participating or have participated in an investigational study, other than this study, within the past 60 days

Treatment and study plan

Hyper-CL™ lens

Device

Regular soft contact lens

Device

Salt solution

Drug

Primary outcomes

  1. frequency and severity of all treatment-related adverse events

    Time frame: Up to 28 days (or 21 days if wash out is not needed).

  2. Percent of subjects with corneal thickness decrease of at least 8% and or visual acuity improvement of at least 1 line following treatment with the Hyper-CL™ lens + salt solution

    Time frame: Up to 28 days (or 21 days if wash out is not needed).

    assess by physiological parameter

Secondary outcomes

  1. Percent of subjects with corneal thickness decrease of at least 8%.

    Time frame: Up to 28 days (or 21 days if wash out is not needed).

    assess by physiological parameter

  2. Percent of subjects with visual acuity improvement of at least 1 line

    Time frame: Up to 28 days (or 21 days if wash out is not needed).

    assess by physiological parameter

  3. Corneal thickness decrease

    Time frame: Up to 28 days (or 21 days if wash out is not needed).

    assess by physiological parameter

  4. change in Measurement Best Corrected Distance Visual Acuity (BCDVA)

    Time frame: Up to 28 days (or 21 days if wash out is not needed).

  5. change in Subject comfort questionnaire

    Time frame: Up to 28 days (or 21 days if wash out is not needed).

Sponsors and collaborators

Lead sponsor

Eye-yon Medical

Industry

Registry information

Official study title

Prospective, Randomized Crossover Study of Using the Hyper-CL™ Lens (Hyper Osmotic Contact Lens) in Subjects Suffering From Corneal Edema

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Jan 21, 2016
Registry last updated
May 21, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.